Cargando…
Cell Death Signaling and Anticancer Therapy
For a long time, it was commonly believed that efficient anticancer regimens would either trigger the apoptotic demise of tumor cells or induce a permanent arrest in the G(1) phase of the cell cycle, i.e., senescence. The recent discovery that necrosis can occur in a regulated fashion and the increa...
Autores principales: | Galluzzi, Lorenzo, Vitale, Ilio, Vacchelli, Erika, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356092/ https://www.ncbi.nlm.nih.gov/pubmed/22655227 http://dx.doi.org/10.3389/fonc.2011.00005 |
Ejemplares similares
-
Past, Present, and Future of Molecular and Cellular Oncology
por: Galluzzi, Lorenzo, et al.
Publicado: (2011) -
Trial Watch: Anticancer radioimmunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013) -
Trial Watch: Proteasomal inhibitors for anticancer therapy
por: Obrist, Florine, et al.
Publicado: (2014) -
An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013) -
Trial watch: Dendritic cell-based interventions for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)